APA (7th ed.) Citation

Janssen, M., Schäkel, U., Djuka Fokou, C., Krisam, J., Stermann, J., Kriegsmann, K., . . . Müller-Tidow, C. (2020). A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial. Current controlled trials in cardiovascular medicine, 21(1), 828-4. https://doi.org/10.1186/s13063-020-04735-y

Chicago Style (17th ed.) Citation

Janssen, Maike, et al. "A Randomized Open Label Phase-II Clinical Trial with or Without Infusion of Plasma from Subjects After Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A Structured Summary of a Study Protocol for a Randomised Controlled Trial." Current Controlled Trials in Cardiovascular Medicine 21, no. 1 (2020): 828-4. https://doi.org/10.1186/s13063-020-04735-y.

MLA (9th ed.) Citation

Janssen, Maike, et al. "A Randomized Open Label Phase-II Clinical Trial with or Without Infusion of Plasma from Subjects After Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A Structured Summary of a Study Protocol for a Randomised Controlled Trial." Current Controlled Trials in Cardiovascular Medicine, vol. 21, no. 1, 2020, pp. 828-4, https://doi.org/10.1186/s13063-020-04735-y.